MFAP4 is a novel prognostic biomarker in glioma correlating with immunotherapy resistance and ferroptosis - Lv, Yuanhao; Gao, Ying; Di, Wenyu; Li, Zhaoyi; Shi, Yashen; Hou, Tianyuan; Chen, Yiyang; Tian, Jiaqi; Xu, Miaoming; Su, Wei; Zhang, Min; Zhong, Jiateng (Frontiers in Pharmacology, 2025)